GlaxoSmithKline Inc. — licence 100630, currently licensed, last inspection rating C (2025-09-15).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02494558 | ACYCLOVIR SODIUM INJECTION | AURO PHARMA INC | Solution | ACYCLOVIR (ACYCLOVIR SODIUM) 50 MG | Marketed |
| 02531224 | ACYCLOVIR SODIUM INJECTION | EUGIA PHARMA INC. | Solution | ACYCLOVIR (ACYCLOVIR SODIUM) 50 MG | Marketed |
| 02236926 | ACYCLOVIR SODIUM INJECTION | FRESENIUS KABI CANADA LTD | Solution | ACYCLOVIR (ACYCLOVIR SODIUM) 50 MG | Marketed |
| 02231357 | ACYCLOVIR SODIUM FOR INJECTION | ABBOTT LABORATORIES, LIMITED | Powder For Solution | ACYCLOVIR (ACYCLOVIR SODIUM) 1 G | Cancelled Post Market |
| 02231356 | ACYCLOVIR SODIUM FOR INJECTION | ABBOTT LABORATORIES, LIMITED | Powder For Solution | ACYCLOVIR (ACYCLOVIR SODIUM) 500 MG | Cancelled Post Market |
| 02231191 | ACYCLOVIR SODIUM FOR INJECTION | NOVOPHARM LIMITED | Powder For Solution | ACYCLOVIR (ACYCLOVIR SODIUM) 1 G | Cancelled Post Market |
| 02231190 | ACYCLOVIR SODIUM FOR INJECTION | NOVOPHARM LIMITED | Powder For Solution | ACYCLOVIR (ACYCLOVIR SODIUM) 500 MG | Cancelled Post Market |
| 02236916 | ACYCLOVIR SODIUM INJECTION | PFIZER CANADA ULC | Solution | ACYCLOVIR (ACYCLOVIR SODIUM) 25 MG | Cancelled Post Market |
| 02239743 | ACYCLOVIR SODIUM INJECTION | IVAX PHARMACEUTICALS INCORPORATED | Solution | ACYCLOVIR (ACYCLOVIR SODIUM) 25 MG | Cancelled Pre Market |
| 02456524 | ACYCLOVIR SODIUM INJECTION | STERIMAX INC | Solution | ACYCLOVIR (ACYCLOVIR SODIUM) 50 MG | Dormant |
| 00899321 | ZOVIRAX | GLAXOSMITHKLINE INC | Powder For Solution | ACYCLOVIR (ACYCLOVIR SODIUM) 1 G | Cancelled Post Market |